Vinpocetine And Blood Flow To The Brain — What The Evidence Shows
Quick Read Vinpocetine is a supplement derived from the periwinkle plant that has been used clinically in Europe and Asia
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Standardised oral lavender oil, specifically a product called Silexan, has been tested in multiple clinical trials and shown real benefits for anxiety. The oil works by calming overactive nerve cells in the brain, similar to how some prescription anxiety medications work, but without causing drowsiness or dependence. Studies show it performs comparably to established drugs like lorazepam and sertraline when measured across 1,172 patients.
The sleep improvement from Silexan is real but indirect, occurring almost entirely because the product reduces anxiety that was keeping people awake. There is also evidence it helps with co-occurring depression and anxiety symptoms. The safety profile is notably strong, with minimal side effects and no risk of dependence, sexual dysfunction, or weight gain that commonly occur with prescription alternatives.
Important caveats exist. Almost all robust evidence is for Silexan specifically at 80 mg daily, not generic lavender products. Long-term data beyond 10 weeks is limited. This should not replace medical care for clinical anxiety or depression, but rather inform conversations with a doctor. For mild to moderate everyday anxiety, the evidence-to-risk ratio is genuinely favourable.
Verdict: Standardised oral lavender oil has credible clinical trial evidence for reducing anxiety and anxiety-related sleep disruption, with an unusually favourable safety profile compared to pharmaceutical alternatives, though quality and dose matter significantly and medical guidance should be sought for serious conditions.
What if one of the most credible anxiety treatments in recent years wasn’t a pharmaceutical at all, but a precisely standardised capsule of lavender oil? Not a room diffuser, not a bath bomb, not a scented candle. An oral dose of a patented lavender essential oil called Silexan, taken once daily, that has now been tested in multiple randomised controlled trials against some of medicine’s most established anti-anxiety drugs, and held its own.
That probably challenges everything you think you know about lavender. Most of us file it under “nice smell, vaguely relaxing, not serious medicine.” But the clinical evidence tells a more interesting story. Over the past decade, a substantial body of human trial data has accumulated around oral lavender oil, enough that researchers are now comparing it directly to lorazepam, paroxetine and sertraline. So let’s look at what the trials actually show, what the numbers say, and where the honest limits of the evidence lie.
Vitacuity has reviewed over 1.77 million research papers and selected the most relevant studies on this topic to bring you a clear, evidence-grounded picture.
Before we get into the trials, it helps to understand what’s actually happening when you swallow a lavender oil capsule, because it’s genuinely different from what happens when you smell one.
The proprietary form of lavender oil used in almost all the clinical research is called Silexan, a standardised essential oil produced by steam distillation from the flowers of *Lavandula angustifolia*. Its two core active components are linalool and linalyl acetate, which are also the main volatile compounds that give lavender its characteristic scent [3].
When Silexan is taken orally, researchers believe it works primarily through voltage-dependent calcium channels (VDCC) in the nervous system [9]. Think of these channels as gates that control how excitable your nerve cells are. When they’re over-active, nerve signalling becomes heightened, which maps onto the physical and mental experience of anxiety. Silexan appears to moderately inhibit specific types of these calcium channels (particularly T-type and N-type channels), calming that overactivation [9].
This is where it gets interesting: the mechanism is somewhat similar to pregabalin, a prescription medication used for anxiety and nerve pain. But unlike pregabalin, Silexan doesn’t appear to cause sedation or carry abuse potential [9]. That distinction matters, a lot, because it means the calming effect isn’t simply “it makes you drowsy.” It appears to be working on anxiety at a more targeted level.
There’s also evidence that Silexan influences neuroplasticity, the brain’s ability to adapt and rewire itself, through activation of signalling pathways involving enzymes called PKA and MAPK, and a transcription factor called CREB. In plain terms: it may support the brain’s natural capacity for recovery and resilience, in a way that’s consistent with how antidepressant drugs are thought to work [9].
Evidence grade: Strong, multiple randomised, double-blind, placebo-controlled trials in humans
The most important thing to know is that Silexan has been tested in five separate double-blind, randomised, placebo-controlled trials in patients with anxiety disorders. That’s not one promising study, it’s a replicable finding across different populations and research groups [8].
A 2015 randomised controlled trial published in *European Neuropsychopharmacology* enrolled 170 outpatients with anxiety-related restlessness and sleep disturbance [6]. Participants received either 80 mg Silexan or placebo once daily for 10 weeks. Using the Hamilton Anxiety Scale (HAMA), the standard clinical measure for anxiety, the Silexan group saw their scores drop from an average of 25.5 to 13.7 points. The placebo group dropped from 26.5 to 16.9. That’s a statistically significant difference (p = 0.03), and nearly half of patients in the Silexan group (48.8%) met the criteria for treatment response, compared to 33.3% on placebo (p = 0.04) [6].
A 2024 individual patient-level meta-analysis in *European Psychiatry* pooled data from all five placebo-controlled Silexan trials, totalling 1,172 patients, and confirmed a significant association between baseline anxiety severity and treatment benefit (p < 0.001) [8]. Crucially, it found Silexan was effective across mild, moderate and severe anxiety presentations. The more severe the starting symptoms, the greater the benefit, but even patients with mild or early-stage anxiety showed meaningful improvement [8].
A 2023 meta-analysis (published separately) specifically examining Silexan’s efficacy across subthreshold anxiety, mixed anxiety-depressive disorder and generalised anxiety disorder further consolidated this picture [15].
Evidence grade: Promising to Strong, direct head-to-head trial data exists, though the overall picture deserves careful reading
This is where the research becomes genuinely striking. The 2025 narrative review published in *European Archives of Psychiatry and Clinical Neuroscience* summarised the comparative trial data [2]:
– Silexan 80 mg/day vs. lorazepam 0.5 mg/day: comparable efficacy for anxiety reduction over 10 weeks [2] – Silexan 80 mg/day vs. paroxetine 20 mg/day: comparable efficacy [2] – Silexan vs. sertraline 50 mg/day in mild-to-moderate major depression: Silexan was superior to placebo and comparably effective to sertraline [2]
The same review noted that Silexan was “not associated with drug interactions, sedation, sleep disturbance, dependence and abuse potential, sexual dysfunction, weight gain or withdrawal symptoms” [2]. For context: sedation, dependence risk and sexual side effects are all commonly reported with the drugs it was compared against.
These are striking findings. We should be careful not to overinterpret them, “comparably effective” in a trial doesn’t automatically mean “interchangeable with” in clinical practice, and we’ll discuss the important caveats below. But as a signal that standardised oral lavender oil is doing something pharmacologically meaningful, this is hard to dismiss.
Evidence grade: Promising, meta-analysis of trial data, but sample sizes and populations need consideration
A 2023 meta-analysis published in *European Archives of Psychiatry and Clinical Neuroscience* re-examined the five placebo-controlled Silexan trials specifically looking at co-occurring depressive symptoms [10]. Using the depressed mood item from the Hamilton Anxiety Rating Scale (HAMA), Silexan showed significantly greater reduction than placebo (p = 0.01). Across three trials that also used validated depression scales (MADRS or HAMD), mean score reductions significantly favoured Silexan over placebo (p < 0.01) [10].
Importantly, patients who had more severe depressive symptoms at the start showed more pronounced improvements, the signal was real and dose-responsive in terms of baseline severity [10].
The 2025 review [2] extended this to patients with mixed anxiety and depressive disorder and noted emerging data suggesting Silexan may benefit individuals experiencing anxiety and depressive symptoms in the context of post-COVID-19 syndrome, though this particular application is newer and requires more dedicated investigation.
The 2025 comprehensive review of lavender’s pharmacology in *Phytomedicine* confirms these findings, noting that clinical studies have established Silexan as “safe and effective for treating anxiety and related diseases” while also identifying antidepressant properties as part of its pharmacological profile [3].
Evidence grade: Strong, mechanism clearly established in randomised trial data
Here’s something genuinely interesting about how Silexan affects sleep. A 2019 study published in the *Journal of Psychiatric Research* analysed sleep outcomes from a double-blind trial of 212 patients taking 80 mg Silexan or placebo for 10 weeks [11]. Sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI), and the results showed Silexan significantly improved sleep (p = 0.002).
But here’s the nuance that makes this research particularly credible: the researchers then ran a mediation analysis to understand *why* sleep improved. Was Silexan sedating people? Or was it something else?
The answer was clear. Approximately 98.4% of the total effect on sleep was mediated by the drug’s effect on anxiety, not by any direct sedative effect [11]. In other words, Silexan improved sleep almost entirely by reducing the anxiety that was disrupting it in the first place. This is consistent with its mechanism of action and explains why it doesn’t cause the drowsiness, next-day grogginess or dependence risk associated with sleep medications [11].
If you’re someone whose sleep is disturbed because your mind won’t quieten down at night, this finding is worth understanding. The benefit isn’t pharmacological sedation, it’s anxiety resolution.
Evidence grade: Promising/Early Stage, small samples, short duration, or confounded by other ingredients
Beyond Silexan, there are a handful of smaller studies worth mentioning, with appropriate caveats about their limitations.
A 2026 randomised controlled trial published in the *Journal of Psychiatric Research* examined lavender tea (2g twice daily for 14 days) in 60 participants diagnosed with misophonia, a condition characterised by heightened sensitivity to specific sounds and associated anxiety, anger and depression [5]. The lavender tea group showed improvements in anxiety, depression, anger and misophonia symptoms compared to controls. However, the study was single-blind (participants knew which group they were in), used self-report measures only, and the researchers themselves noted findings should be “interpreted cautiously in terms of placebo effects and expectancy bias” [5]. Consider this interesting but not yet definitive.
A 2004 double-blind crossover trial studied the EEG brain activity of 16 healthy volunteers after taking a lozenge containing lavender oil alongside extracts of hops, lemon balm and oat [13]. The combination product increased alpha-1, alpha-2 and beta-1 electrical power at multiple brain sites, patterns associated with relaxation and reduced anxious arousal. The study is small and the product was a combination (so you can’t attribute the effect to lavender alone), but the neurological signal is consistent with the broader mechanistic story [13].
A 2026 triple-blind randomised clinical trial on aromatherapy lavender during dental surgery found significant reductions in heart rate, respiratory rate, local anaesthetic requirements and cortisol levels in the lavender group compared to controls [4]. This involved inhalation rather than oral administration, a different delivery route, but the cortisol finding is notable: it suggests a genuine physiological stress response, not just a subjective “feeling calmer” [4].
Good research always comes with honest limits. Here’s what the evidence doesn’t yet tell us clearly:
The exact molecular mechanism isn’t fully mapped. While the calcium channel hypothesis is compelling and supported by pharmacological data [9], researchers acknowledge that the precise sequence of events at the cellular level, how exactly linalool and linalyl acetate produce their effects in the human brain, hasn’t been completely characterised. Animal models and cell studies support the picture, but human mechanistic studies are still needed [3].
Most trials involve the same proprietary product. Almost all the robust human evidence is for Silexan specifically, a standardised, patented essential oil from *Lavandula angustifolia*. We cannot automatically assume that other lavender oil products, capsules, teas or supplements will produce the same results. Standardisation matters enormously in herbal medicine, and a lavender capsule you pick up without knowing its linalool content is not the same thing as what’s been tested in trials [3].
Long-term data is limited. The vast majority of trials run for 10 weeks. We don’t yet have strong data on what happens at six months, a year, or beyond. Does the benefit persist? Is there any tolerance? These are unanswered questions [2].
The PTSD application is still protocol-only. A 2026 paper registered a 12-week randomised controlled trial of Silexan as an adjunctive treatment for PTSD [1][7]. This is a fascinating direction but we’re in the protocol stage, no results yet. Don’t draw conclusions from it in either direction.
Comparator trial interpretation needs care. While the head-to-head data against lorazepam, paroxetine and sertraline is intriguing [2], these comparisons are not a signal to self-treat serious clinical anxiety or depression with lavender instead of seeking medical support. The trials were conducted in controlled settings with specific patient populations and standardised dosing. If you’re on medication, the conversation about alternatives belongs with your doctor.
The tea and combination product studies are underpowered. The lavender tea trial [5] and the EEG lozenge study [13] are too small and too short, or too confounded by other ingredients, to draw firm conclusions. Interesting signals, not established findings.
So what does a sensible, well-informed person do with all of this?
First, let’s be clear about what the evidence supports: oral lavender oil in a standardised, tested form (Silexan, 80 mg/day) has a genuinely strong body of trial evidence behind it for anxiety reduction, multiple randomised controlled trials, over 1,000 patients pooled, consistent results, and a safety profile that is frankly enviable compared to pharmaceutical alternatives [2][8]. The sleep benefit is real but indirect, it follows from anxiety reduction [11]. There’s also credible evidence for a mood benefit in people with co-occurring depression and anxiety [10].
Here’s how to think about this practically:
If you’re experiencing day-to-day anxiety, tension, restlessness or disrupted sleep that seems anxiety-driven, oral standardised lavender oil is one of the few herbal interventions with real clinical trial backing. It’s not a placebo effect dressed up in lavender. It has a plausible mechanism, it’s been tested against established drugs, and it’s demonstrated safety across multiple trials with no serious adverse events beyond occasional mild digestive discomfort (mainly burping from the oil) [2].
Standardisation is everything. The trials used Silexan, 80 mg once daily of a specific, standardised lavender essential oil. If you’re going to try this, look for a product that specifies its linalool content and is produced from *Lavandula angustifolia*. A generic lavender oil capsule of unknown composition is a different product entirely [3].
It’s not a replacement for medical care. If you’re experiencing clinical anxiety disorder or depression that’s affecting your quality of life, that conversation belongs with a GP or mental health professional. The trial data showing Silexan comparable to lorazepam and sertraline is genuinely interesting, but those comparisons were made in supervised trials, not as a DIY experiment. Use this information to have a more informed conversation with your doctor, not to avoid one.
For mild-to-moderate everyday anxiety and anxiety-driven sleep disruption, the risk-benefit profile is unusually favourable. No sedation, no dependence risk, no withdrawal, no sexual side effects, no weight gain, no known drug interactions at normal doses [2]. That’s a safety profile most anti-anxiety medications can’t match. The cost is low. The evidence is real. The downside is minimal.
The burping, incidentally, is real, it’s the one consistently reported side effect. Lavender oil capsules can cause mild eructation (polite word for burping that smells of lavender). Most people find this manageable. A few don’t. Worth knowing in advance.
Lavender has been used for calm for thousands of years. The 21st century has done something useful: it’s taken that tradition seriously, standardised it, and tested it properly. The result is one of the more credible natural interventions in the mental health supplement space. Not magic. Not a miracle. But meaningfully, measurably real.
[1] The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) trial: protocol for a 12-week randomised controlled trial of adjunctive Silexan for PTSD (2026). DOI: 10.1186/s12906-026-05312-7 | https://pubmed.ncbi.nlm.nih.gov/41736003/
[2] Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data (2025). DOI: 10.1007/s00406-024-01923-8 | https://pubmed.ncbi.nlm.nih.gov/39453446/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500767/
[3] Lavender: phytochemistry, pharmacology, cross-disciplinary applications, and clinical efficacy (2025). DOI: 10.1016/j.phymed.2025.157274 | https://pubmed.ncbi.nlm.nih.gov/41014669/
[4] Aromatherapy with lavender essential oil for the control of dental anxiety in patients undergoing dental surgery: A triple-blind randomized clinical trial (2026). DOI: 10.17219/dmp/186872 | https://pubmed.ncbi.nlm.nih.gov/41553229/
[5] The effect of lavender herbal tea on the mental health of individuals with misophonia: A randomized controlled trial (2026). DOI: 10.1016/j.jpsychires.2026.01.028 | https://pubmed.ncbi.nlm.nih.gov/41579454/
[6] Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep, A randomized, placebo-controlled trial (2015). DOI: 10.1016/j.euroneuro.2015.07.024 | https://pubmed.ncbi.nlm.nih.gov/26293583/
[7] The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) trial: protocol for a 12-week randomised controlled trial of adjunctive Silexan for PTSD (2026). DOI: 10.1186/s12906-026-05312-7 | https://pubmed.ncbi.nlm.nih.gov/41736003/
[8] Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials (2024). DOI: 10.1192/j.eurpsy.2024.16 | https://pubmed.ncbi.nlm.nih.gov/38425206/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10966615/
[9] Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender (2021). DOI: 10.1016/j.neuint.2020.104899 | https://pubmed.ncbi.nlm.nih.gov/33181239/
[10] Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited (2023). DOI: 10.1007/s00406-022-01390-z | https://pubmed.ncbi.nlm.nih.gov/35262795/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958187/
[11] Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect (2019). DOI: 10.1016/j.jpsychires.2019.04.013 | https://pubmed.ncbi.nlm.nih.gov/31121394/
[13] Effects of lozenge containing lavender oil, extracts from hops, lemon balm and oat on electrical brain activity of volunteers (2004). https://pubmed.ncbi.nlm.nih.gov/15546807/
[15] Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials (2023). https://pubmed.ncbi.nlm.nih.gov/36717399/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Vinpocetine is a supplement derived from the periwinkle plant that has been used clinically in Europe and Asia
Quick Read Standard curcumin supplements are poorly absorbed by your body because curcumin doesn’t dissolve well in water and is
The nutrients that matter, the forms that work, and the claims to ignore.
